Shares of EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) rose 17.3% during mid-day trading on Thursday . The stock traded as high as $0.20 and last traded at $0.18. Approximately 297 shares changed hands during trading, a decline of 92% from the average daily volume of 3,950 shares. The stock had previously closed at $0.15.
EOM Pharmaceuticals Trading Up 12.2 %
The company’s fifty day moving average price is $0.23 and its 200-day moving average price is $0.27.
EOM Pharmaceuticals Company Profile
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Featured Articles
- Five stocks we like better than EOM Pharmaceuticals
- Dividend Payout Ratio Calculator
- MarketBeat Week in Review – 4/15 – 4/19
- Upcoming IPO Stock Lockup Period, Explained
- Comprehensive Analysis of PayPal Stock
- What is the FTSE 100 index?
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
